ReviewFrontiers in pediatrics2026
An overview of the placenta's role in the development of congenital diaphragmatic hernia.
Review in Frontiers in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Congenital diaphragmatic hernia (CDH) is a severe congenital malformation resulting from incomplete diaphragm development, leading to abdominal organ herniation into the thoracic cavity. This disruption compromises pulmonary development, frequently resulting in lung hypoplasia and pulmonary hypertension. While the role of the placenta in congenital heart defects is well established, its involvement in congenital lung diseases, particularly CDH, remains unexplored. During the prenatal period, the placenta serves as a crucial site for nutrient and gas exchange between the mother and the fetus, and given its functional connection to fetal development, it provides a compelling avenue for investigating the pathophysiology of CDH. This review synthesizes current knowledge regarding the placental contribution to CDH, with a focus on molecular pathways, particularly the retinoic acid pathway and placental abnormalities. Evidence from both animal models and human studies suggests a complex interplay between placental function and CDH pathogenesis. Further investigation is required to elucidate the placenta's role in disease mechanisms, which may offer perspectives for future research, advances in prenatal diagnostics, and therapeutic strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.